LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 9,932 | N/A | 20,620 |
| Marketable Securities | N/A | N/A | 37,028 | N/A | 37,900 |
| Other current assets | 0 | 0 | 0 | 0 | 1,480 |
| TOTAL | $N/A | $N/A | $47,528 | $N/A | $60,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1,921 | N/A | N/A |
| Intangibles | 0 | 0 | 2,237 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1,880 |
| TOTAL | $N/A | $N/A | $4,158 | $N/A | $1,880 |
| Total Assets | $N/A | $N/A | $51,686 | $N/A | $63,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 743 | 0 | 620 |
| Accrued Expenses | N/A | N/A | 2,231 | N/A | 2,020 |
| TOTAL | $N/A | $N/A | $3,141 | $N/A | $2,890 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $3,141 | $N/A | $2,890 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 353 | N/A | 350 |
| Retained earnings | N/A | N/A | -110,249 | N/A | -98,220 |
| Other shareholders' equity | 0 | 0 | 218 | 0 | 160 |
| TOTAL | $N/A | $N/A | $48,545 | $N/A | $60,420 |
| Total Liabilities And Equity | $0 | $0 | $51,686 | $0 | $63,310 |